Archive:
What opportunities does digitalization offer for improving medical care? What beneficial solutions already exist, and how are they perceived by doctors and patients? Using diabetes as an example, the Digitalization and Technology Report (DUT), a truly unique project combining primary data collection and analysis of key topics, not only depicts the status quo but also aims to offer hope, alleviate anxieties, and highlight problem areas. The DUT Report is edited by Professors Dr. Bernhard Kulzer and Dr. Lutz Heinemann, and sponsored and co-initiated by the pharmaceutical company Berlin-Chemie, which is represented in an interview with "Monitor Versorgungsforschung" by Michael Bollessen and Dr. Anja Selig.
07.06.2021
Commentary by Dr. Dr. Klaus Piwernetz (medimaxx health management GmbH, Munich) and Univ.-Prof. Dr. Dr. hc Edmund A. M. Neugebauer (President of the Brandenburg Medical School)
07.06.2021
Comment by Dr. PH Dipl.-Stat. Carsten Schwenke (SCO:SSiS Statistical Consulting, Berlin)
07.06.2021
The COVID-19 crisis has not only exposed the causes of supply disruptions for system-critical medical devices and pharmaceuticals and made the consequences of the digitalization gap in the healthcare system transparent, but has also revealed, in particular, the consequences of fundamental leadership deficiencies in hospital personnel management, professional and regulatory policies, and procurement management. The pandemic has also triggered a rethinking of values, the meaning and purpose of work content and behavioral norms, as well as the role and significance of "bedside professionals" in society. There is an urgent need for action on the part of policymakers, unions, associations, and hospital managers to make working conditions for "bedside professionals" more family-friendly and to sustainably improve their remuneration. Likewise, the government must create incentives for building domestic reserve production capacities for system-critical medical devices and pharmaceuticals, establish a value-based tendering process, prepare a "National Buying Center for Crisis Situations," and shorten global supply chains to facilitate their management and increase security of supply.
07.06.2021
Since the establishment of the Charité Health Services Research Congresses, health services research at Charité, an institution previously heavily focused on basic research—particularly in the field of neuroscience—has become not just a visible part, but a "very visible component of the research strategy at Charité," as Prof. Dr. Axel R. Pries (Dean of Charité) stated in his welcoming address for the 2021 congress (see MVF 02/21). These congresses are organized by the Charité Health Services Research Platform, which in turn originated from an initiative of the Institute of Medical Sociology and Rehabilitation Science (IMSR), the Institute of General Practice, the Institute of Public Health, and the Department of Emergency and Acute Medicine (CCM/CVK) (see MVF 01/20). The increasing importance of health services research for Charité is demonstrated by no fewer than five new professorships in this field.
07.06.2021
The group of authors supplements the statements from theses 4 and 6.1 with a third ad hoc statement on intensive care. In correction of the version from May 16, 2021, in Chap. 4 the numbers of patients treated in intensive care are based on the daily value, the hospitalization/intensive care ratio is corrected to the length of stay of 10 days (Table 3) and a footnote (No. 30) is added which deals with the possible explanation for the decrease in the total intensive care bed capacity by outsourcing the pediatric intensive care beds. As of: May 16, 2021, 12:00 p.m., update from May 17, 2021
07.06.2021
On the occasion of the current legislative process for the 4th Civil Protection Act, the group of authors is supplementing its previous seven theses with a second urgent ad hoc statement. “The “Emergency Brake Act” is highly problematic from a constitutional and legal policy perspective. It links the entry of z. Sometimes serious encroachments on fundamental rights are disproportionate to a politically arbitrary and uncertain “threshold value” that is unsuitable as a control value and can also be influenced by the new tests. The law shortens the legal protection, reduces it to legal actions for the control of norms or (limited) constitutional complaints and completely excludes the administrative legal process, which actually represents an indispensable legal protection for citizens for these encroachments on fundamental rights. The federalist principle is disavowed and any approach to differentiated measures to combat pandemics is excluded.
07.06.2021
Berichte über seltene schwere Komplikationen im Zusammenhang mit der Verwendung des „Vaxzevria“-Impfstoffes von AstraZeneca haben zu einer erheblichen Verunsicherung der Impflinge geführt. Dazu schreibt das renommierte „Winton Centre for Risk and Evidence Communication“ der Universität Cambridge (Prof. David Spiegelhalter): „Alle medizinischen Behandlungen haben sowohl potenzielle Schäden als auch potenziellen Nutzen, und es ist wichtig, diese gegeneinander abwägen zu können“. In dem Artikel „Communicating the potential benefits and harms of the Astra-Zeneca Covid-19-vaccine“ (1) berichtet das Winton Centre über den potenziellen Nutzen und Schaden des Covid-19-Impfstoffs von AstraZeneca in Abhängigkeit von Alter und Expositionsrisiko. Demnach überwiegt der potenzielle Nutzen (vermiedene Aufnahme in die Intensivstation) die potenziellen Schäden (Blutgerinnsel) bei weitem. Nur bei Menschen unter 30, die ein geringes Expositionsrisiko haben, bringt das Impfen keinen Vorteil. Dazu meint Prof. Woods, ehemaliger Chef der Britischen Zulassungsbehörde, nach einem Bericht der „Financial Times“ (2), dass es „auf dem Kontinent keine solche evidenzbasierte Analyse“ gäbe und er den Eindruck habe, dass man dort „die Zahlen aus der Luft gegriffen“ habe.
07.06.2021
Results of a Delphi survey and retrospective data analysis
07.06.2021
Health, its maintenance and promotion are central tasks in health care. However, curative medicine alone is increasingly reaching its limits in order to counteract the consequences of chronic diseases in view of the demographic development in our “society of longer life” (Special report 2009 p. 18 ff, Expert Council “Coordination and Integration – Health care in a society of longer life” )1. These findings contributed to the evidence-based development of the general medical and specialist medical full care contracts on the part of the AOK Baden-Württemberg, among other things, to promote the biopsychosocial perspective, including non-drug care, and to agree on this as a common basis with the medical outpatient contractual partners, for example Back pain and many other growing problems caused by civilization.